Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hoechst-Roussel Agri-Vet was a prominent animal health company formed through the partnership of Hoechst AG and Roussel Uclaf. The company specialized in the development, manufacturing, and marketing of veterinary pharmaceuticals and biologics for livestock and companion animals. Its product portfolio included well-known parasiticides, anti-infectives, and endocrine products. In the late 1990s, the business was integrated into Hoechst Roussel Vet before being acquired by Intervet (Akzo Nobel) in 1999. Today, its legacy products are part of the Merck Animal Health (MSD Animal Health) portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hoechst-Roussel Agri-Vet.